Skip to main content
Top
Published in: Rheumatology International 5/2004

01-09-2004 | Case Report

Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction

Authors: S. I. Lee, H. S. Jeon, W. H. Yoo

Published in: Rheumatology International | Issue 5/2004

Login to get access

Abstract

Dementia is a very rare neurological manifestation of systemic lupus erythematosus (SLE) and has a deep link with antiphospholipid antibodies (APL) and cerebral infarction in its development. However, nonvascular dementia irrelevant to APL or cerebral infarction has not been reported in patients with SLE until now. We describe a case of reversible dementia in an SLE patient without APL or cerebral infarction which was successfully treated with corticosteroid and cyclophosphamide. There are two significant points in this case. One is that humoral factors other than APL might be involved in the development of dementia. Secondly, reversible dementia without APL or cerebral infarction may respond more favorably to immunosuppressive therapy.
Literature
1.
go back to reference [No authors listed] (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599–608CrossRefPubMed [No authors listed] (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599–608CrossRefPubMed
2.
go back to reference West SG (1996) Lupus and central nervous system. Curr Opin Rheumatol 8:408–414PubMed West SG (1996) Lupus and central nervous system. Curr Opin Rheumatol 8:408–414PubMed
3.
go back to reference Baca V, Lavalle C, Garcia R, Catalan T, Sauceda JM, Sanchez G, Martinez I, Ramirez ML, Marquez LM, Rojas JC (1999) Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 26:432–439PubMed Baca V, Lavalle C, Garcia R, Catalan T, Sauceda JM, Sanchez G, Martinez I, Ramirez ML, Marquez LM, Rojas JC (1999) Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 26:432–439PubMed
4.
go back to reference Mok CC, Lau CS, Wong RW (2001) Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28:766–771PubMed Mok CC, Lau CS, Wong RW (2001) Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28:766–771PubMed
5.
go back to reference Cummings JL, Benson DF (1992) Dementia: a clinical approach. 2nd edn. Butterworth-Heinemann, Boston Cummings JL, Benson DF (1992) Dementia: a clinical approach. 2nd edn. Butterworth-Heinemann, Boston
6.
go back to reference Asherson RA, Mercey D, Phillips G, Sheehan N, Gharavi AE, Harris EN, Hughes GR (1987) Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 46:605–611PubMed Asherson RA, Mercey D, Phillips G, Sheehan N, Gharavi AE, Harris EN, Hughes GR (1987) Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 46:605–611PubMed
7.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed
8.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) ‘Minimental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMed Folstein MF, Folstein SE, McHugh PR (1975) ‘Minimental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMed
9.
go back to reference Crookes TG (1974) Indices of early dementia on WAIS. Psychol Rep 34:734PubMed Crookes TG (1974) Indices of early dementia on WAIS. Psychol Rep 34:734PubMed
10.
go back to reference Kirk A, Kertesz A, Polk MJ (1991) Dementia with leukoencephalopathy in systemic lupus erythematosus. Can J Neurol Sci 18:344–348PubMed Kirk A, Kertesz A, Polk MJ (1991) Dementia with leukoencephalopathy in systemic lupus erythematosus. Can J Neurol Sci 18:344–348PubMed
11.
go back to reference Levine SR, Welch KMA (1987) The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 44:876–883PubMed Levine SR, Welch KMA (1987) The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 44:876–883PubMed
12.
go back to reference Coull BM, Bourdette DN, Goodnight SH Jr, Briley DP, Hart R (1987) Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 18:1107–1112PubMed Coull BM, Bourdette DN, Goodnight SH Jr, Briley DP, Hart R (1987) Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 18:1107–1112PubMed
13.
go back to reference Gorman DG, Cumminges JL (1993) Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsychiatry Clin Neurosci 5:37–42PubMed Gorman DG, Cumminges JL (1993) Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsychiatry Clin Neurosci 5:37–42PubMed
14.
go back to reference Greaves M (1999) Antiphospholipid antibodies and thrombosis. Lancet 353:1348–1353PubMed Greaves M (1999) Antiphospholipid antibodies and thrombosis. Lancet 353:1348–1353PubMed
15.
go back to reference Ferro D, Basili S, Roccaforte S, Di Franco M, Cipollone F, Ciabattoni G, Davi G (1999) Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. Arthritis Rheum 42:2689–2697CrossRefPubMed Ferro D, Basili S, Roccaforte S, Di Franco M, Cipollone F, Ciabattoni G, Davi G (1999) Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. Arthritis Rheum 42:2689–2697CrossRefPubMed
16.
go back to reference Hactrinski VC, Lassen MA, Marshall J (1974) Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 2:207–210CrossRefPubMed Hactrinski VC, Lassen MA, Marshall J (1974) Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 2:207–210CrossRefPubMed
17.
go back to reference Lojkowska W, Ryglewicz D, Jedrzejczak T, Sienkiewicz-Jarosz H, Minc S, Jakubowska T, Kozlowicz-Gudzinska I (2002) SPECT as a diagnostic test in the investigation of dementia. J Neurol Sci 203-204:215–219 Lojkowska W, Ryglewicz D, Jedrzejczak T, Sienkiewicz-Jarosz H, Minc S, Jakubowska T, Kozlowicz-Gudzinska I (2002) SPECT as a diagnostic test in the investigation of dementia. J Neurol Sci 203-204:215–219
18.
go back to reference Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260PubMed Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260PubMed
19.
go back to reference Van Horn G, Arnett FC, Dimachkie MM (1996) Reversible dementia and chorea in a young woman with the lupus anticoagulant. Neurology 46:1599–1603PubMed Van Horn G, Arnett FC, Dimachkie MM (1996) Reversible dementia and chorea in a young woman with the lupus anticoagulant. Neurology 46:1599–1603PubMed
20.
go back to reference Lai NS, Lan JL (2000) Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 9:353–357PubMed Lai NS, Lan JL (2000) Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 9:353–357PubMed
21.
go back to reference Isshi K, Hirohata S (1998) Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 41:1819–1827CrossRefPubMed Isshi K, Hirohata S (1998) Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 41:1819–1827CrossRefPubMed
22.
go back to reference Denburg JA, Behmann SA (1994) Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kD reactivity. Ann Rheum Dis 53:304–308PubMed Denburg JA, Behmann SA (1994) Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kD reactivity. Ann Rheum Dis 53:304–308PubMed
23.
go back to reference Hanly JG, Hong C, Smith S, Fisk JD (1999) A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42:728–734CrossRefPubMed Hanly JG, Hong C, Smith S, Fisk JD (1999) A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42:728–734CrossRefPubMed
24.
go back to reference Kovacs JA, Urowitz MB, Gladman DD (1993) Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am 19:795–814PubMed Kovacs JA, Urowitz MB, Gladman DD (1993) Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am 19:795–814PubMed
25.
go back to reference Hermosillo-Romo D, Brey RL (2002) Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best Pract Res Clin Rheumatol 16:229–244CrossRefPubMed Hermosillo-Romo D, Brey RL (2002) Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best Pract Res Clin Rheumatol 16:229–244CrossRefPubMed
26.
go back to reference Navarrete MG, Brey RL (2000) Neuropsychiatric systemic lupus erythematosus. Curr Treat Options Neurol 2:473–485PubMed Navarrete MG, Brey RL (2000) Neuropsychiatric systemic lupus erythematosus. Curr Treat Options Neurol 2:473–485PubMed
Metadata
Title
Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction
Authors
S. I. Lee
H. S. Jeon
W. H. Yoo
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2004
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0405-1

Other articles of this Issue 5/2004

Rheumatology International 5/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.